UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation Journal article
Cao, Dai, Chen, Die, Xia, Jiang Nan, Wang, Wen Yan, Zhu, Guo Yuan, Chen, Li Wen, Zhang, Chuantao, Tan, Bo, Li, Hui, Li, Ying Wei. Artesunate promoted anti-tumor immunity and overcame EGFR-TKI resistance in non-small-cell lung cancer by enhancing oncogenic TAZ degradation[J]. Biomedicine and Pharmacotherapy, 2022, 155.
Authors:  Cao, Dai;  Chen, Die;  Xia, Jiang Nan;  Wang, Wen Yan;  Zhu, Guo Yuan; et al.
Favorite | TC[WOS]:10 TC[Scopus]:10  IF:6.9/6.8 | Submit date:2023/01/31
Anti-tumor Immunity  Artesunate  Egfr-tki Resistance  Non-small-cell Lung Cancer  Pd-l1  Taz  
Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells Journal article
Yang X., Chu Y., Wang Y., Guo Q., Xiong S.. Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells[J]. Vaccine, 2006, 24(15), 2966-2974.
Authors:  Yang X.;  Chu Y.;  Wang Y.;  Guo Q.;  Xiong S.
Favorite | TC[WOS]:13 TC[Scopus]:13 | Submit date:2019/01/16
4t1  Anti-tumor Immunity  Itac